| Papers [1-15] of 100 :: [Page 1 of 7] | | Go to page : 1 2 3 4 5 6 7 —> | Search results on "TRUMAN JOHNSON CRISIS ASIA": |
|
|
Truman and Johnson: Crisis in Asia, 2006.
This paper examines the Korean and Vietnam wars as well as the various similarities shared by both President Harry S. Truman and President Lyndon B. Johnson during their terms in office.
2,958 words (approx. 11.8 pages), 2 sources, APA, $ 87.95
»
Click here to show/hide summary
Abstract
The writer of this paper explores the ironic similarities shared by Presidents Truman and Johnson, who both inherited the office of president at the death of their predecessors, both were extremely popular leaders and both died while in office. It is another irony that each president became embroiled in a war in Asia. This paper discusses both wars in detail as well as the events that led up to the conflicts including the fact that the Korean war set a precedent for the Vietnam War. This paper also examines the different leadership styles of both presidents, including the manner in which Truman kept firm control over the military while Johnson accepted most military assessments at face value. This paper also contemplates how these two conflicts effectively ended the public life of both Truman and Johnson, bringing an end to each one's administration.
From the Paper
"Earlier in January, 1968 the Tet Offensive attempt to take over the American Embassy had been a turning point in the war. Five of South Vietnam's six major cities, 36 of its 44 provincial capitals, and 66 of the 242 district towns were attacked. American losses were heavier than ever before, 3,895 men killed in eight weeks. South Vietnamese forces sustained much smaller losses, but there were an estimate 14,000 noncombatant men, women and children who were killed in the campaign. Although the Communist offensive was ultimately to lose 58,000 men in the offensive, the action drew even more dissent at home. The protestors were not now only the radicals and students, but mainstream voters were also increasingly expressing their opposition lining up in a groundswell of support for presidential Robert Kennedy, who pledged to end the war, as were members of the president's cabinet."
| |
|
Financial Crisis in Asia, 2002.
Examines the economic problems which face Asia today.
2,400 words (approx. 9.6 pages), 15 sources, $ 89.95
»
Click here to show/hide summary
Abstract
This paper examines the financial crisis in Asia. It outlines the problem in broad details. It focuses on a regional production network/'flying geese' argument to provide an explanation. It also explores the unique effects the crisis had in China.
| |
|
Currency and Financial Crisis in Southeast Asia, 2004.
This paper analyzes the Asian financial crisis of 1997-1998 in Korea, Thailand, Malaysia, and the Philippines.
6,090 words (approx. 24.4 pages), 28 sources, MLA, $ 143.95
»
Click here to show/hide summary
Abstract
This study applies ordinary least squares (OLS) estimation procedures, with and without lags, to identify the causes of currency crises in selected economies during the 1997-98 East Asian currency and financial crisis. The author states that the cause of the crisis was attributed to initial macroeconomic conditions, weak macroeconomic fundamentals, financial sector regulation, and policy reaction. The paper relates that the empirical results were consistent with previous literature on currency crises; episodes of depreciation appear to be associated with the depletion of foreign exchange reserves and the increase in foreign liabilities. Equations. Tables.
Table of Contents
Introduction
Classical Theory
Empirical Research Explaining Currency Crisis
First Generation Models
Second Generation Models
Third Generation Models
Policy Reactions and the Role of the IMF
Conceptual Model
Initial Conditions
Deterioration of Macroeconomic Fundamentals
International Sector and Financial Regulation
Macroeconomic Policy
Ideal and Actual Data
Measuring the Symptoms
Measuring Currency Crisis
Actual Data
Results and Analysis
Conclusion
Appendix I: Summary of Data and Indicators Used in Previous Studies
Appendix II: General F-Tests
Appendix III: Statistical Analysis for Multicollinearity and Heteroskedasticity
Appendix IV: E-views Output of Granger Causality Tests
From the Paper
"Although Korea, the Philippines and Thailand followed the classic prescription of raising their interest rate to defend their currencies, all three saw continued depreciations, well in excess of what would be predicted by the currency crisis models Furman and Stiglitz (1997). From a policy perspective, Goldfajn and Gupta (1998) look the real exchange rate ?undervaluation? episodes in 80 countries following the crises to assess whether tight monetary policy brings about a recovery in the real exchange rate through a nominal appreciation of the exchange rate. They find that in their total sample, tight monetary policy increases the probability of recovery by about 10 percentage points. But among countries undergoing simultaneous banking and currency crisis, as in East Asia, tight monetary policy is associated with roughly 10 percentage points lower probability of success. Both of these differences are statistically significant."
| |
|
Russian Financial Crisis 1998: A Self-made Crisis, 2002.
A paper that covers the financial crisis that hit Russia in August 1998.
4,694 words (approx. 18.8 pages), 14 sources, MLA, $ 120.95
»
Click here to show/hide summary
Abstract
This paper contains an analysis of factors, both internal and external, that caused the financial crisis in Russia in 1988. The main argument of the paper is that the main causes of the crisis originated from inside. The monetary system that the Russian government created after the fall of the USSR failed to provide a stable channel for the implementation of an adequate monetary policy. The paper shows that the banking system was ill-designed and corrupt, mainly serving as a channel for government funds to favored industries. Finally, the paper shows that the extreme usage of government debt (often for the personal benefit of the Russian officials) was the factor that shut the whole economy down. Bonds were printed like paper, which is unsustainable even in the short-run.
Table of Contents:
A Self-made Crisis
Fake Monetary System
The Banks that Weren?t
Russian FIGs
A Pyramid of Bonds
The Fall of the Babylon
The Responsibility
Works Cited
From the Paper
"In 1998 Russia was hit by a large-scale financial crisis. The bad news of Russian default (or payment suspension) in August 1998 was one of the primary concerns of almost all Russian and western media. The events and outcomes of the crisis were relatively similar to the ones that took place in Asia in 1997 or, more recently, in Argentina (the latter has recently defaulted on the largest government debt in history). These amounted, but were not limited to: national currency being largely devaluated, collapse of the banking system, and political unrest resulting in dramatic changes in the government."
| |
|
Energy Crisis Causes Governor Crisis, 2002.
An overview of the Californian energy crisis and its impact on the Governer's hopes for re-election.
1,150 words (approx. 4.6 pages), 4 sources, $ 44.95
»
Click here to show/hide summary
Abstract
This paper explores the recent energy crisis in California and how that affects the Governor and his hopes for re-election. A chronological explanation of the crisis is provided as well as some thoughts about the political problems this is going to cause for the governor in the future.
| |
|
Public Relations and Johnson & Johnson, 2005.
An examination of how Johnson and Johnson handled the crisis about the Tylenol medication.
1,208 words (approx. 4.8 pages), 5 sources, MLA, $ 41.95
»
Click here to show/hide summary
Abstract
This paper explains that when the crisis with Tylenol happened, in the 1980s, people were less in tune with public relations and the ramifications. The writer examines how the company dealt with the crisis and concludes that had this happened today, the results would have been far worse for the company.
From the Paper
"Johnson and Johnson has been a very broadly based organization that has been manufacturing health care products since a very long time. It started its footsteps as a child in the mid 1880s with the production of ready-to-use, ready-made surgical dressing. It was the first company to have applied the theory of wound treatment by use of antiseptics. With its application, the chances of infection in postoperative patients reduced greatly. General Robert Wood Johnson wrote the Company's Credo in 1943 which explained the responsible approach of Johnson and Johnson in carrying out their business. It states that the Company's initial most responsibility is to serve the people who make use of their services and products. Second in their priority list comes the employees followed by the environment and community and the last being the stockholders. This shows that Company had aimed to serve the consumers and wished to provide them with the best. It had also envisioned that if the first three priorities were met, the last one i.e. the stockholders, would be fulfilled automatically. "The philosophy at Johnson & Johnson is, 'All accidents and injuries are preventable. An accident is the end result of a unique chain of events and conditions. The role of all Johnson & Johnson employees is to foresee these acts and intercept them before they occur,' says Van Houten" (Smith, 2003). Health and safety are of utmost importance to Johnson and Johnson and they do not allow factors such as profits, sales and production to compromise the safety and health issues. During 1944, Johnson and Johnson became public from a privately held organization. Johnson and Johnson later realized its need to expand and diversify its business and during the 1950s, it entered into pharmaceuticals and later on produced Tylenol, a well known pain killer."
| |
|
Johnson & Johnson, 2005.
This paper discusses the Johnson & Johnson company especially its major brand-drug Tylenol.
1,660 words (approx. 6.6 pages), 13 sources, MLA, $ 53.95
»
Click here to show/hide summary
Abstract
This paper explains that, since the 1885 partnership of the Johnson brothers, Johnson & Johnson has had a remarkable growth, world-wide especially, after World War II, when a plan of decentralizing operations was introduced, dividing the consumer market under the brand Johnson & Johnson and the professional markets under the current Ethicon brand label. The author points out that the Tylenol product not only has had problem with product tampering, which led to the introduction of tamper-proof packaging, but also this drug is deemed as having a narrower range between therapeutic and toxic than any other non-prescription drug especially for children. The paper concludes that, today, Johnson & Johnson is (1) a stable company with acceptable growth, but not as venturesome or dynamic in product innovations as some of its rivals and (2) is know as a family-friendly place to work with opportunities, especially for women and minorities.
From the Paper
"Saachi & Saatchi, one of the world's largest advertising agencies, handles some of Johnson & Johnson's consumer products advertising. Tylenol continues its campaign to promote its products as being used and recommended by health care professionals and used in hospitals more than any other "pain reliever". Pepcid AC has a strong campaign, positioned against other antacids as being able to be taken BEFORE a meal, as well as after. Feminine hygiene products are advertised most frequently in soap operas and other programming, aimed at women, of course. It is likely that in the coming year, the Nicorette brand anti-smoking products will increase their coverage, being outspent by rival Nicoderm. Rumors of a Nicorette product (perhaps a chewing gum) aimed at helping teens to stop smoking are not confirmed by the company."
| |
|
Johnson & Johnson, Inc., 2005.
This paper is a fundamental analysis of Johnson & Johnson, Inc., the world's most comprehensive and broadly based manufacturer of health care products and related services, for the consumer, pharmaceutical, medical devices and diagnostics markets.
3,960 words (approx. 15.8 pages), 10 sources, MLA, $ 107.95
»
Click here to show/hide summary
Abstract
This paper is a stock analysis of Johnson & Johnson, Inc. and their efforts at reducing costs, increasing market share, meeting their shareholders and stakeholders as well as industry expectations while still fulfilling the very high levels of quality demanded by their customers. The author uses the Capital Asset Pricing Model, which takes into consideration the inherent risk that is associated with any investment and the rates of return, to determine that Johnson & Johnson's return on investment must be greater than a return of 6.07 percent. The paper concludes that, through new acquisitions, novel business strategies and a regular migration to cheaper labor pools, Johnson & Johnson Inc has become a strong force to be reckoned with in the highly competitive major drugs and healthcare industry; the author recommends a buy order at $60. Illustration. Charts. Tables.
Table of Content
Introduction
Economic and Market Analysis
Globalization
Industry Analysis
Company Analysis
Brief History of the Company
Analysis of Capital Asset Pricing Model
Intrinsic Value
Recommendation and Conclusion
Appendix A: Valuation Measures
Appendix B: Trading Information
Appendix C: Competitors
Appendix D: Awards & Recognition
From the Paper
"The company has a long history of innovation and success. The founders created the first 'ready-made, ready-to-use surgical dressings' and initiated the way for 'application of the theory of antiseptic wound treatment' in the mid-1880's. These new products and services concepts literally reduced the threat of infection and disease in postoperative victims and helped save many lives in the early days of modern medicine. "The story begins with the discoveries of Sir Joseph Lister, a noted English surgeon, who identified airborne germs as a source of infection in the operating room. He called them, with grim aptness, the "invisible assassins." Medical science was beginning to understand, however imperfectly, the need for greater care in protecting the wound area."
| |
|
Johnson & Johnson: Social Responsibility, 2007.
Examines how the Johnson & Johnson company can be considered a model of corporate social responsibility.
6,050 words (approx. 24.2 pages), 15 sources, MLA, $ 143.95
»
Click here to show/hide summary
Abstract
This paper argues that Johnson & Johnson is a prime example of a company directed by "virtue ethics." As evidenced by the Tylenol crises, J&J executives do not resort to a moral calculus (Utilitarianism) or a deontological (rule-based) method of ethical decision making (Kant). The paper evaluates the company in terms of corporate control devices, stakeholder theory, the CSR pyramid, Kohlberg's theory of moral development and ethical theory.
Outline:
Introduction
Company History
The Tylenol Crisis
The Evaluation
References
From the Paper
"When all was said and done the recall of Tylenol* alone cost Johnson & Johnson over $100 million. Prior to the crisis, Tylenol held a 37% market share, outselling its four nearest competitors combined. Within weeks after the crisis its market share had dropped to 7%. When asked about the future of Tylenol, Madison Avenue guru Jerry Della Femina told a New York Times reporter "I don't think they (J&J) can ever sell another product under that name.""
| |
|
Johnson & Johnson's Marketing Mix, 2006.
A review of Johnson & Johnson (JNJ), a recognized global leader and manufacturer of health care products.
3,003 words (approx. 12.0 pages), 5 sources, MLA, $ 88.95
»
Click here to show/hide summary
Abstract
This paper reviews and discusses the global leader in health care products, Johnson & Johnson (JNJ). According to the paper, JNJ has over 200 subsidiaries with offices in nearly every nation of the world. The paper reports that Johnson & Johnson has gone through a variety of structural and organizational structures in the last twenty years and today is centered on a market segment-based approach which comprises their consumer, medical devices & diagnostics and pharmaceuticals businesses.
Outline:
Company Description
Business Segments are aligned to Target Markets
Pharmaceutical Segment
Medical Devices & Diagnostics
Consumer
Product Strategy
Pricing Strategies
Distribution Strategy
Promotions and Marketing Communications
Conclusion
From the Paper
"JNJ's move into markets that require more sophistication in drug development and production is also exemplified by their move into the market for medications to treat Schizophrenia, an area of their business that made up 18% of total 2006 pharmaceutical revenues. The anemia market is another source of challenge for the company as price erosion has been necessary to stem market share losses. We assume revenue erosion in the mid-single digits over the next 3 years with continued competition from Amgen and some modest negative effects from Roche's Cera, expected to launch in May 2007. The anemia franchise (Procrit/Eprex) made up 14% of JNJ's pharmaceutical sales in 2006.
The MD&D division has enjoyed industry leadership, particularly at the company's Cordis business. This previously fast-growing business made up 20% of JNJ's MD&D sales in 2006 and a significant proportion of its profit. Noteworthy competition from Boston Scientific, Abbott, and Medtronic is likely to erode market share beginning in 2007, driving Cordis sales declines in the range of 4% to 19% in 2007-10. The Conor acquisition is expected to be successful.The Consumer division should benefit from the recent acquisition of Pfizer's consumer line."
| |
|
Johnson & Johnson, 2002.
A company overview of healthcare products producer Johnson and Johnson.
1,150 words (approx. 4.6 pages), 3 sources, $ 44.95
»
Click here to show/hide summary
Abstract
This five-page undergraduate paper studies the history of growth of one of the most well known healthcare companies; Johnson & Johnson. The company is known for its quality products and its innovative spirit; it has made significant contribution in the introduction of antiseptic practices in hospitals.
| |
|
?Johnson & Johnson? as a Rational Organization, 2002.
An examination of the factors that give 'Johnson & Johnson, Co." a rational organizational structure.
980 words (approx. 3.9 pages), 3 sources, MLA, $ 34.95
»
Click here to show/hide summary
Abstract
The paper defines rational organizations as those which seek to develop structure and coordinate their activities in response to technical requirements and in relation to the complexity of the task environment they face. The paper shows how 'Johnson & Johnson' has established its mission and vision by putting in place a rational organizational structure, defining reporting relationships, establishing a project management methodology and infrastructure, developing a communications plan in support of the group's global leadership role, creating position descriptions, and recruiting. A history of the company is also discussed.
From the Paper
"Johnson & Johnson attributes the success of its organization structure to its management of each separate part as part of a functioning, single entity. By grouping its global affiliates into three business segments and then overlaying each segment and its affiliates with a transparent structure of alignment, Johnson & Johnson has created a unique organization structure."
| |
|
Johnson and Johnson, 2005.
A corporate analysis of the the company Johnson and Johnson.
1,564 words (approx. 6.3 pages), 6 sources, MLA, $ 51.95
»
Click here to show/hide summary
Abstract
The purpose of this paper is to introduce the reader to the Johnson and Johnson Corporation and its financial status. It begins with a brief history of the company and its products and its operational conditions. The paper also explores current methods to assess the company's financial condition which include looking at their annual report to analyze different financial indicators. The tools used are ratio analysis and leverage analysis with a brief explanation of how these tools work. It then evaluates the company by examining what they done to maximize their potential and what are they planning on doing in the future to remain solid. It concludes with recommendations for the company to maximize their potential.
Outline
Introduction
Operational Conditions
The Marketplace
Change and Expectation
Financial Conditions
Financial Highlights
Recommendation
From the Paper
"Johnson and Johnson does business within the healthcare sector and has industry membership in the major drug field. Because of the nature of this industry and the risk involved with drug manufacture, it can be very difficult to gage and predict its performance over time. Right now the drug industry is suffering the fallout from the recall of Celebrex. There are also other warnings being recently about other drugs such as Strattera. There has been much media scrutiny of the FDA and its prior approval of drugs like Accutane. What does this mean for the market and its companies? For the future, it may mean increased drug testing, which can be extremely costly, and time consuming."
| |
|
Johnson & Johnson, 2004.
An analysis of the medical products company, Johnson & Johnson, including recent financial tables.
2,757 words (approx. 11.0 pages), 6 sources, MLA, $ 82.95
»
Click here to show/hide summary
Abstract
This paper presents a background and analysis of Johnson & Johnson. The paper begins with an explanation of J&J's business, which ranges from medical and health products to wider consumer products, such as talcum powder and cotton wool. The writer believes the company is an excellent example of a good, strong company that places consumer interests first.
Contents
Historical Background
Economic Foundation of the Company
Tables
Consumer Relations
References
From the Paper
"On the basis of information provided by Hoover?s (2003), in 1885, in Brunswick, NJ, James and Edward Mead Johnson founded their medical products company and were soon joined by their brother, Robert in 1886. Robert had developed an antiseptic surgical dressing that he wanted to have produced through the company. This represented the beginnings of one of the leading companies in a multitude of industries, including pharmaceutical manufacturing, medical devices and diagnostics manufacturing, and consumer products manufacturing. As Johnson & Johnson moved into the 20th century, the company continued to develop and manufacture products that would long come to be associated its? name."
| |
|
Johnson & Johnson, 1994.
This paper is a financial analysis using liquidity ratios for 1990 to 1992 of Johnson and Johnson, the largest and most comprehensive health care company in the world: Debt, equity, profit margin. Tables.
1,125 words (approx. 4.5 pages), 7 sources, $ 39.95
»
Click here to show/hide summary
From the Paper
"Johnson and Johnson is the largest and most comprehensive health care company in the world, offering a broad line of consumer products, prescription and over-the-counter pharmaceuticals, and various other medical and dental items. Johnson and Johnson brands include Tylenol, Band-Aid and Reach. The company has a large international business (contributing 49 percent of sales in 1993) and is divided into three major operating segments: consumer, professional and pharmaceutical.. This research examines the company's financial performance for the period 1990 - 1992 through the use of ratio analysis. A complete table of the ratios used in this document is provided on page six.
Liquidity ratios are used to determine the ability of a company to meet its current (short-term) obligations. Common measure ... "
|
|
|
